Antonio Giordano

56.1k total citations · 12 hit papers
874 papers, 36.6k citations indexed

About

Antonio Giordano is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonio Giordano has authored 874 papers receiving a total of 36.6k indexed citations (citations by other indexed papers that have themselves been cited), including 414 papers in Molecular Biology, 393 papers in Oncology and 135 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonio Giordano's work include Cancer-related Molecular Pathways (196 papers), Ubiquitin and proteasome pathways (64 papers) and Epigenetics and DNA Methylation (58 papers). Antonio Giordano is often cited by papers focused on Cancer-related Molecular Pathways (196 papers), Ubiquitin and proteasome pathways (64 papers) and Epigenetics and DNA Methylation (58 papers). Antonio Giordano collaborates with scholars based in United States, Italy and United Kingdom. Antonio Giordano's co-authors include Umberto Galderisi, Cristina Giacinti, Antonio De Luca, Giuseppina Tommonaro, Silvia Lapenna, Pier Paolo Claudio, Alfonso Baldi, Margaret M. Kasten, Luigi Bagella and Maria Laura Avantaggiati and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Antonio Giordano

852 papers receiving 36.0k citations

Hit Papers

RB and cell cycle progression 1992 2026 2003 2014 2006 1992 2019 2009 1997 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RB and cell cycle progression
    2006 921 citations Antonio Giordano et al. profile →
  2. Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle
    1992 911 citations Antonio Giordano et al. profile →
  3. Curcumin and Cancer
    2019 747 citations Antonio Giordano et al. Nutrients profile →
  4. Cell cycle kinases as therapeutic targets for cancer
    2009 745 citations Antonio Giordano et al. profile →
  5. Recruitment of p300/CBP in p53-Dependent Signal Pathways
    1997 585 citations Antonio Giordano et al. profile →
  6. Cell Cycle and Apoptosis
    2000 545 citations Antonio Giordano et al. profile →
  7. From Cell–ECM interactions to tissue engineering
    2003 507 citations Francesco Rosso, Antonio Giordano et al. Journal of Cellular Physiology profile →
  8. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells
    2007 485 citations Antonio Giordano et al. Journal of Cellular Physiology profile →
  9. Role of p53 in the Regulation of Cellular Senescence
    2020 408 citations Antonio Giordano et al. profile →
  10. p53 signaling in cancer progression and therapy
    2021 339 citations Andrea Morrione, Antonio Giordano et al. profile →
  11. Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
    2023 270 citations Alfredo Caturano, Vincenzo Russo et al. profile →
  12. Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures
    2018 254 citations Paola Indovina, Andrea Chirico et al. profile →

Peers

Antonio Giordano
Comparison fields: 5 of 204
  • Molecular Biology 19.5k
  • Oncology 13.8k
  • Cancer Research 6.3k
  • Pulmonary and Respiratory Medicine 4.1k
  • Genetics 3.0k
Gerry Melino Italy
Lin Zhang China
Robert J. Coffey United States
Takashi Takahashi Japan
Doménico Ribatti Italy
Qing‐Yu He China
Yuquan Wei China
Michael Dean United States
Yasunori Okada Japan
Jian Zhang China
Gerry Melino Italy View profile →
Citations per field, relative to Antonio Giordano
Antonio Giordano · 1×
Citations per year, relative to Antonio Giordano
Antonio Giordano · 1×

Countries citing papers authored by Antonio Giordano

Since Specialization
Citations

This map shows the geographic impact of Antonio Giordano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Giordano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Giordano more than expected).

Fields of papers citing papers by Antonio Giordano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Giordano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Giordano. The network helps show where Antonio Giordano may publish in the future.

Co-authorship network of co-authors of Antonio Giordano

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Giordano. A scholar is included among the top collaborators of Antonio Giordano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Giordano. Antonio Giordano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Electrochemical (bio)sensors for cancer therapy monitoring Electrochimica Acta Sima Singh, Antonella Miglione et al. 2
2 Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad European Journal of Clinical Investigation Alfredo Caturano, Enes Erul et al. 0
3 Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence Journal of Clinical Medicine Alfredo Caturano, Biagio Liccardo et al. 5
4 Capsaicin Exerts Antitumor Activity in Mesothelioma Cells Nutrients Aurora Costa, Sara Damiano et al. 4
5 The Role of FBXW7 in Gynecologic Malignancies Cells Riccardo Di Fiore, Rosa Drago‐Ferrante et al. 10
6 Artificial Protein Coronas Enable Controlled Interaction with Corneal Epithelial Cells: New Opportunities for Ocular Drug Delivery Pharmaceutics Sara Palchetti, Mina Massaro‐Giordano et al. 12
7 RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways Cancers Carmelina Antonella Iannuzzi, Francesca Pentimalli et al. 9
8 Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade Cancers Paola Indovina, Iris Maria Forte et al. 7
9 Effects of δ‐tocotrienol on ochratoxin A—induced nephrotoxicity in rats Journal of Cellular Physiology Sara Damiano, Luigi Navas et al. 19
10 Effect of sex steroid hormone fluctuations in the pathophysiology of male‐retinal pigment epithelial cells Journal of Cellular Physiology Carlo Astarita, Mina Massaro‐Giordano et al. 2
11 CDK9: A key player in cancer and other diseases Journal of Cellular Biochemistry Fátima Morales, Silvia Boffo et al. 97
12 Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs Journal of Cellular Physiology Annamaria Cimini, Michele d’Angelo et al. 21
13 Past and future of stem cells: from Prometheus to regenerative medicine SHILAP Revista de lepidopterología Gavino Faa, Vassilios Fanos et al. 1
14 Psychosocial Outcomes of Quadrantectomy Versus Mastectomy in a Southern Italian Sample: Development and Needs of the Italian Derriford Appearance Scale 24. PubMed Timothy Moss, Andrea Chirico et al. 1
15 MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells International Journal of Oncology Riccardo Di Fiore, Rosa Drago‐Ferrante et al. 55
16 Establishment and Validation of Circulating Tumor Cell–Based Prognostic Nomograms in First-Line Metastatic Breast Cancer Patients Clinical Cancer Research Antonio Giordano, Brian L. Egleston et al. 36
17 Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth Clinical Cancer Research Emanuela Leone, Eugenio Morelli et al. 184
18 The zebrafish as a model for nociception studies Journal of Cellular Physiology Valentina Malafoglia, Bruce P. Bryant et al. 52
19 Rosso F, Marino G, Giordano A, Barbarisi M, Parmeggiani D, Barbarisi A. Smart materials as scaffolds for tissue engineering, Journal of Cellular Physiology (2005) 203(3) 465–470 Journal of Cellular Physiology Francesco Rosso, G. Marino et al. 1
20 Cell cycle: Molecular targets for diagnosis and therapy: Tumor suppressor genes and cell cycle progression in cancer Journal of Cellular Biochemistry Antonio Giordano, Youcef M. Rustum et al. 21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerry Melino Breakdown of academic impact, for papers by Lin Zhang Breakdown of academic impact, for papers by Robert J. Coffey Breakdown of academic impact, for papers by Takashi Takahashi Breakdown of academic impact, for papers by Doménico Ribatti Breakdown of academic impact, for papers by Qing‐Yu He Breakdown of academic impact, for papers by Yuquan Wei Breakdown of academic impact, for papers by Michael Dean Breakdown of academic impact, for papers by Yasunori Okada Breakdown of academic impact, for papers by Jian Zhang
Rankless by CCL
2026